Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Maladministration of the AS01B Adjuvant of Shingrix Alone; Patient may only have received Shingrix diluent vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in two patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Maladministration of the AS01B Adjuvant of Shingrix Alone) and inappropriate dose of vaccine administered (Verbatim: Patient may only have received Shingrix diluent vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date: 23-MAY-2025 The reporter reported that a patient may only had received Shingrix diluent vaccine. Do not have the information on the patient at this time or if this was a first or second dose. Two diluents missing from the box and two powders left, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The Vaccine Administration Facility is the same as Primary Reporter.